Weiner, Howard L.
Weiner, Howard L., 1944-
Howard L. Weiner American neurologist, neuroscientist and immunologist
VIAF ID: 25900990 (Personal)
Permalink: http://viaf.org/viaf/25900990
Preferred Forms
- 100 0 _ ‡a Howard L. Weiner ‡c American neurologist, neuroscientist and immunologist
-
-
-
- 100 1 _ ‡a Weiner, Howard L
-
-
- 100 1 _ ‡a Weiner, Howard L.
- 100 1 _ ‡a Weiner, Howard L.
-
-
- 100 1 _ ‡a Weiner, Howard L.
-
-
- 100 1 _ ‡a Weiner, Howard L. ‡d 1944-
- 100 1 _ ‡a Weiner, Howard L. ‡d 1944-
- 100 1 _ ‡a Weiner, Howard L. ‡d 1944-
-
-
4xx's: Alternate Name Forms (5)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
The brain under siege : solving the mystery of brain disease, and how scientists are following the clues to a cure | |
Casos clínicos de neurologia para o médico interno | |
The children's ward | |
Curing MS : how science is solving the mysteries of multiple sclerosis | |
Leczenie immunosupresyjne w stwardnieniu rozsianym | |
Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. | |
Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells | |
A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study | |
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. | |
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. | |
Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant | |
Multiple sclerosis : a subject collection from Cold Spring Harbor perspectives in medicine | |
Multiple Sclerosis Diagnosis and Therapy | |
Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells | |
A nasal proteosome adjuvant activates microglia and prevents amyloid deposition | |
Neurologia / Howard L. Weiner, Lawrence P. Levit. - Wroclaw, 1997. | |
Neurology | |
Neurology for the house officer | |
Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. | |
New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity | |
Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. | |
OR.102. The CD58 Pathway is Implicated in MS Susceptibility | |
Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells | |
Oral tolerance : mechanisms and applications : [conference held in New York City on March 30 - April 2, 1995, by the New York academy of sciences] | |
Oral tolerance : new insights and prospects for clinical application | |
Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. | |
Oral tolerance to copolymer 1 in myelin basic protein | |
Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment | |
PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. | |
PD-L1<sup>+</sup> and XCR1<sup>+</sup> dendritic cells are region-specific regulators of gut homeostasis | |
Pediatric neurology for the house officer | |
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity | |
Power estimation for non-standardized multisite studies | |
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. | |
Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy. | |
Rate of brain atrophy in benign vs early multiple sclerosis. | |
Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells. | |
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. | |
The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis | |
REMOVED: Identification of a unique molecular and functional microglia signature in health and disease | |
Retinal pigment epithelial cells induce foxp3(+) regulatory T cells via membrane-bound TGF-β. | |
Rinshō shinkeigaku no jissai | |
Role of the innate immune system in the pathogenesis of multiple sclerosis | |
Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression | |
Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters. | |
Serum antibodies to phosphatidylcholine in MS | |
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis | |
The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction | |
Short Report: A Pilot Study of a Group Positive Psychology Intervention for Patients with Multiple Sclerosis. | |
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis | |
SUMMIT | |
SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts | |
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS. | |
Survivin controls biogenesis of microRNA in smokers: A link to pathogenesis of rheumatoid arthritis. | |
Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples. | |
Systems biology approaches for the study of multiple sclerosis | |
T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice | |
Targeting latency-associated peptide promotes antitumor immunity. | |
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. | |
Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity | |
Time-series modeling of multiple sclerosis disease activity: a promising window on disease progression and repair potential? | |
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. | |
Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis | |
Treatment satisfaction in multiple sclerosis | |
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. | |
Understanding natural and pathological autoimmunity | |
Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis. | |
Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life | |
γδ T cells control humoral immune response by inducing T follicular helper cell differentiation | |
신경학 | |
臨床医のための小児神経学 | |
臨床神経学の実際 |